Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Molecular Cancer Therapeutics
|
October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
Karen E Parrish, Ling Cen, James Murray, et al.
Blood
|
April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
Michael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
Scientific Reports
|
November 18, 2023
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy
Darcy L Welch, Brooke L Fridley, Ling Cen, et al.
The Journal of Investigative Dermatology
|
June 20, 2020
Noninvasive Assessment of Epidermal Genomic Markers of UV Exposure in Skin
Elnara Muradova, Nishit Patel, Brittney Sell, et al.
Nature Communications
|
August 17, 2019
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
Yu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Nature Communications
|
March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
Yu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Cancer Immunology Research
|
April 18, 2025
Antitumor CD4+ T Helper 1 Cells Target and Control the Outgrowth of Disseminated Cancer Cells
Ganesan Ramamoorthi, Marie Catherine Lee, Carly M Farrell, et al.
Nature Communications
|
May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial
Jeffrey S Johnson, Justin W Miller, Firas Hatoum, et al.
Blood Cancer Discovery
|
April 16, 2021
TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia
Seongseok Yun, Nicole D Vincelette, Xiaoqing Yu, et al.
Journal of the National Cancer Institute
|
November 29, 2015
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
Shiv K Gupta, Sani H Kizilbash, Brett L Carlson, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Molecular Cancer Therapeutics
|
October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
Karen E Parrish, Ling Cen, James Murray, et al.
Blood
|
April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
Michael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
Scientific Reports
|
November 18, 2023
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy
Darcy L Welch, Brooke L Fridley, Ling Cen, et al.
The Journal of Investigative Dermatology
|
June 20, 2020
Noninvasive Assessment of Epidermal Genomic Markers of UV Exposure in Skin
Elnara Muradova, Nishit Patel, Brittney Sell, et al.
Nature Communications
|
August 17, 2019
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
Yu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Nature Communications
|
March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
Yu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Cancer Immunology Research
|
April 18, 2025
Antitumor CD4+ T Helper 1 Cells Target and Control the Outgrowth of Disseminated Cancer Cells
Ganesan Ramamoorthi, Marie Catherine Lee, Carly M Farrell, et al.
Nature Communications
|
May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial
Jeffrey S Johnson, Justin W Miller, Firas Hatoum, et al.
Blood Cancer Discovery
|
April 16, 2021
TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia
Seongseok Yun, Nicole D Vincelette, Xiaoqing Yu, et al.
Journal of the National Cancer Institute
|
November 29, 2015
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
Shiv K Gupta, Sani H Kizilbash, Brett L Carlson, et al.
Page
of 8